Assertio Holdings Inc (ASRT)
1.00
-0.01
(-0.99%)
USD |
NASDAQ |
May 24, 16:00
1.01
+0.01
(+1.00%)
After-Hours: 20:00
Assertio Holdings Enterprise Value: 52.69M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 52.69M |
| May 23, 2024 | 53.65M |
| May 22, 2024 | 56.50M |
| May 21, 2024 | 54.60M |
| May 20, 2024 | 56.50M |
| May 17, 2024 | 59.35M |
| May 16, 2024 | 54.60M |
| May 15, 2024 | 53.65M |
| May 14, 2024 | 53.65M |
| May 13, 2024 | 57.45M |
| May 10, 2024 | 48.89M |
| May 09, 2024 | 57.45M |
| May 08, 2024 | 57.93M |
| May 07, 2024 | 63.16M |
| May 06, 2024 | 73.62M |
| May 03, 2024 | 55.55M |
| May 02, 2024 | 53.65M |
| May 01, 2024 | 45.20M |
| April 30, 2024 | 41.76M |
| April 29, 2024 | 38.23M |
| April 26, 2024 | 36.35M |
| April 25, 2024 | 32.25M |
| April 24, 2024 | 39.91M |
| April 23, 2024 | 44.08M |
| April 22, 2024 | 39.88M |
| Date | Value |
|---|---|
| April 19, 2024 | 31.10M |
| April 18, 2024 | 29.29M |
| April 17, 2024 | 31.77M |
| April 16, 2024 | 33.26M |
| April 15, 2024 | 35.04M |
| April 12, 2024 | 40.16M |
| April 11, 2024 | 41.49M |
| April 10, 2024 | 42.96M |
| April 09, 2024 | 43.86M |
| April 08, 2024 | 45.34M |
| April 05, 2024 | 47.72M |
| April 04, 2024 | 45.38M |
| April 03, 2024 | 45.49M |
| April 02, 2024 | 45.98M |
| April 01, 2024 | 46.59M |
| March 31, 2024 | 48.81M |
| March 28, 2024 | 55.89M |
| March 27, 2024 | 58.81M |
| March 26, 2024 | 61.66M |
| March 25, 2024 | 63.56M |
| March 22, 2024 | 63.56M |
| March 21, 2024 | 64.51M |
| March 20, 2024 | 63.56M |
| March 19, 2024 | 60.71M |
| March 18, 2024 | 63.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.500M
Minimum
Apr 03 2020
656.53M
Maximum
Jun 28 2019
197.30M
Average
140.63M
Median
Enterprise Value Benchmarks
| Ocular Therapeutix Inc | 481.15M |
| Vertex Pharmaceuticals Inc | 107.75B |
| Cormedix Inc | 222.84M |
| Verastem Inc | 56.41M |
| CytomX Therapeutics Inc | -13.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.51M |
| Revenue (Quarterly) | 32.45M |
| Total Expenses (Quarterly) | 36.06M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 65.55% |
| Profit Margin (Quarterly) | -13.90% |
| Earnings Yield | -366.0% |
| Normalized Earnings Yield | -126.92 |